Abstract Body

Background: The hepatitis E virus (HEV) is a small, fecal-orally transmitted RNA virus with a worldwide distribution. There are multiple genotypes which are associated with both host and geographic specificity. In resource-limited regions of the world, large epidemics of acute hepatitis associated with HEV are common during periods of flooding, or with poor sanitation in refugee camps and during military conflict. The endemic nature of the infection in Western countries has not been widely recognized. It seems to be highly associated with exposure to swine and swine products infected with HEV genotype 3. Misclassification of acute hepatitis as drug injury, which was actually attributable to acute HEV infection has been described. Testing for HEV remains problematic. Recent data suggests that HEV is highly prevalent in those with HCV, though the transmission epidemiology of this finding is uncertain. Furthermore, in immunosuppressed hosts, including those with HIV infection, as well as transplant recipients the virus is capable of establishing a chronic infection which can be associated with progressive hepatic fibrosis. HEV viral clearance with ribavirin, interferon, or withdrawal of immunosuppression has been described. Conclusions: HEV is increasingly recognized as a cause of both acute and chronic liver injury in the United States and other Western countries. Chronic infection can lead to progressive liver injury and cirrhosis in immunosuppressed hosts.